Neuland Laboratories Limited (NEULANDLAB.BO)

7,141.90 -398.80 (-5.29%) At close: 03:29PM IST

Neuland Laboratories Limited

Phoenix IVY Building
11th Floor, 5th Office Level Plot No.573A-III, Road No. 82 Jubilee Hills
Hyderabad 500033
India
91 40 6761 1600
https://www.neulandlabs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 1,554

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Davuluri Rama Mohan Rao	Executive Chairman & Chief Promoter	60M	N/A	1944
Mr. Davuluri Sucheth Rao	Vice Chairman & CEO	57.5M	N/A	1975
Mr. Davuluri Saharsh Rao	Vice Chairman & MD	57.5M	N/A	1979
Mr. Abhijit Majumdar	Chief Financial Officer	N/A	N/A	N/A
Dr. Sharadsrikar V. Kotturi	Chief Scientific Officer	N/A	N/A	N/A
Ms. Sarada Bhamidipati	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Y. Sudheer	Head of Marketing	N/A	N/A	1963
Mr. Shashank Mahashabde	President of Business Development & Contract Manufacturing	N/A	N/A	N/A
Mr. Ashutosh Kumar Sinha	Chief Quality Officer	N/A	N/A	N/A
Mr. Bharadwaj Gollapudi	Deputy General Manager	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Corporate Governance

Neuland Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.